Statistical analysis Procedures were based on non parametric analyses (Mann- Whitney); comparisons between the different groups were made using a two-tailed T-test. Statistical analysis was performed using the SPSS statistical package (SPSS Inc. Chicago, Illinois, USA). Acknowledgments We thank Alan Michael Rosen and Jody Rogan for a critical reading of the manuscript and valuable grammatical advice. We are grateful to Prof. References 1. Barlogie B, Shaughnessy J, Tricot G, Jacobson J, Zangari M, et al. (2004) Treatment of multiple myeloma. Blood 103: 20–32. 2. Van Imhoff GW, Van der Holt B, MacKenzie MA, Van’t Veer MB, Wijermans PW, et al. (2005) Impact of three course of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-Hodgkin’s lymphoma: comparative aanalysis of Ditch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40. J Clin Oncol 23: 3793–3801. 3. Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, et al. (1997) Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89: 3700–3707. 4. Guillaume T, Rubinstein DB, Symann M (1998) Immune reconstitution after autologous hematopoietic stem cell transplantation. Blood 92: 1471–1490. 5. Reimer P, Kunzmann V, Wilhelm M, Weissbrich B, Kraemer D, et al. (2003) Cellular and umoral immune reconstitution after autologous peripheral blood stem cell transplantation (PBSCT). Ann Haematol 82: 263–270. 6. Ferrari V, Cacere CR, Machado CM, Pannuti CS, Dulley FL, et al. (2006) Distinct patterns of regeneration of central memory, effector memory and effector T CD8+ cell subsets after different hematopoietic cell transplant types: possible influence in the recovery of anti-cytomeglovirus immune response and risk for its reactivation. Clin Immunol 119: 261–271. 7. Lossos IS, Breuer R, Or R, Strauss N, Elishoov H, et al. (1995) Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 60: 672–678. 8. Chandrasekar PH, Abraham OC, Klein J, Alangaden G, Chalasani G, et al. (2001) Low infectious morbidity after intensive chemotherapy and autologous peripheral blood progenitor stem cell transplantation in the outpatient setting for women with breast cancer. Clin Infect Dis 32: 546–551. 9. Frere P, Pereira M, Fillet G, Beguin Y (2006) Infections after CD34-selected or unmanipulated autologous hematopietic stem cell transplantation. Eur J Haematol 76: 102–108. 10. Reich G, Mapara MY, Reichardt P, Do¨rken B, Maschmeyer G (2001) Infectious complications after high-dose chemotherapy and autologous stem cell trans- plantation: comparison between patients with lymphoma or multiple myeloma and patients with solid tumors. Bone Marrow transplant 27: 525–529. 11. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, et al. (1999) Surveillance for AIDS-defining opportunistic illnesses, 1992–1997. MMWR CDC Surveill Summ 48: 1–22. 12. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, et al. (1989) Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, HIV- seropositive patients: indipendence of CD4+ cell numbers and clinical staging. J Clin Invest 84: 1892–1899. 13. Clerici M, Stocks NI, Zajac RA, Boswell RN, Bernstein DC, et al. (1989) IL-2 production permits detection of antigenic peptide recognition by T helper lymphocytes from asymptomatic, HIV seropositive individuals. Nature 339: 383–385. 14. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al. (2001) Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410: 106–111. Lymphocytes in ASCT and HIV Mauro Moroni for his continuous support and for helpful discussion. We particularly thank all the patients participating in the study, and the staff of the Institute of Infectious Diseases and Tropical Medicine, ‘Luigi Sacco’ Hospital who cared for the patients. Author Contributions Conceived and designed the experiments: AB DT GM EMP FF MC AG. Performed the experiments: DT MP FF. Analyzed the data: AB ES MC GM MC AG. Contributed reagents/materials/analysis tools: AB DT. Wrote the paper: AB MC AG. 15. Hess C, Altfeld M, Thomas SY, Addo MM, Rosenberg ES, et al. (2004) HIV-1 specific CD8+ T cells with an effector phenotype and control of viral replication. Lancet 363: 863–866. 16. Harari A, Vallelian F, Pantaleo G (2004) Phenotypic heterogeneity of antigen- specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol 34: 3525–3533. 17. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966–72. 18. Palmer BE, Boritz E, Wilson CC (2004) Effects of sustained HIV-1 plasma viremia on HIV-gag-specific CD4+ T cell maturation and function. J Immunol 172: 3337–3347. 19. Younes SA, Yassine-Diab B, Dumont A, Boulassel MR, Grossman Z, et al. (2003) HIV-1 viremia prevents the establishments of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity. J Exp Med 198: 1909–1922. 20. Ellfsen K, Harari A, Champagne P, Bart PA, Sekaly RP, Pantaleo GP (2002) Distribution and functional analysis of memory antiviral CD8 T cell responses in HIV-1 and cytomegalovirus infections. Eur J Immunol 32: 3756–3764. 21. Harari A, Vallelian F, Meylan PR, Pantaleo G (2005) Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J Immunol 174: 1037–1045. 22. Harari A, Petitpierre S, Vallelian F, Pantaleo G (2004) Skewed representation of functionally distinct populations of virus-specific CD4 T cells in HIV-1-infected subjects with progressive disease: changes after antiretroviral therapy. Blood 103: 966–72. 23. Harari A, Rizzardi GP, Ellefsen K, Ciuffreda D, Champagne P, et al. (2002) Analysis of HIV-1 and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood 100: 1381–7. 24. Appay V, Nixon DF, Donahoe SM, Gillespie GM, Dong T, et al. (2000) HIV- specific CD8+ T cells produce antiviral cytokines but are impaired in cytolitic function. J Exp Med 192: 63–75. 25. Trabattoni D, Piconi S, Biasin M, Rizzardini G, Migliorino M, et al. (2004) Granule-dependent mechanisms of lysis are defective in CD8+ T cells of HIV- infected, antiviral-therapy treated individuals. AIDS 18: 859–869. 26. Migueles SA, Laborico AC, Shupert WL, Sabbaghian MS, Rabin R, et al. (2002) HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat Immunol 3: 1061–8. 27. Groschlu¨ter M, Glasmacher A, Sarazin S, Hackbarth F, Hoebert E, et al. (2007) CD4+ T lymphocyte counts after autologous transplantation in multiple myeloma: a retrospective study. Leuk Lymphoma 48: 506–12. 28. Kieper WC, Troy A, Burghardt JT, Ramsey C, Lee JY, et al. (2005) Cutting edge: recent immune status determines the source of antigens that drive homeostatic T cell expansion. J Immunol 174: 3158–3163. 29. Inokuma M, dela Rosa C, Schmitt C, Haaland P, Siebert J, et al. (2007) Functional T cell responses to tumor antigens in brest cancer patients have a distinct phenotype and cytokine signature. J Immunol 179: 2627–33. 30. Bourgeois C, Tanchot C (2003) CD4 T cells are required for CD8 T cell memory generation. Eur J Immunol 33: 3225–31. PLoS ONE | www.plosone.org 8 October 2008 | Volume 3 | Issue 10 | e3616